CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference27 articles.
1. Cancer statistics;Siegel,2018
2. Pancreatic cancer: advances in treatment, results and limitations;Hackert;Dig Dis,2013
3. Underutilization of surgical resection in patients with localized pancreatic cancer;Riall;Ann Surg,2007
4. Recent progress in pancreatic cancer;Wolfgang;CA A Cancer J Clin,2013
5. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies;Garrido-Laguna;Nat Rev Clin Oncol,2015
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab‐paclitaxel chemotherapy: A multicenter retrospective cohort study (PC‐CURE‐1);Journal of Hepato-Biliary-Pancreatic Sciences;2024-08-16
2. Emerging role of local treatment in the era of advanced systemic treatment in pancreatic cancer with liver metastasis: A systematic review and meta‐analysis;Journal of Hepato-Biliary-Pancreatic Sciences;2024-07-17
3. Surgical management of non-colorectal non-neuroendocrine liver oligometastases: Sarcoma, breast, gastric, and pancreatic cancers;Clinical Surgical Oncology;2024-06
4. Should liver metastases of pancreatic adenocarcinoma be resected?;Journal of Visceral Surgery;2024-04
5. Faut-il réséquer les métastases hépatiques d’adénocarcinome du pancréas ?;Journal de Chirurgie Viscérale;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3